272 related articles for article (PubMed ID: 17304448)
1. The role of ancillary antimicrobial therapy for treatment of uncomplicated skin infections in the era of community-associated methicillin-resistant Staphylococcus aureus.
Gorwitz RJ
Clin Infect Dis; 2007 Mar; 44(6):785-7. PubMed ID: 17304448
[No Abstract] [Full Text] [Related]
2. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.
Ruhe JJ; Smith N; Bradsher RW; Menon A
Clin Infect Dis; 2007 Mar; 44(6):777-84. PubMed ID: 17304447
[TBL] [Abstract][Full Text] [Related]
3. Management of methicillin-resistant Staphylococcus aureus (MRSA) skin infections and MRSA colonization.
Terushkin V; Brownell I
J Drugs Dermatol; 2008 Jun; 7(6):597-601. PubMed ID: 18561595
[No Abstract] [Full Text] [Related]
4. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
Lawrence KR; Golik MV; Davidson L
Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
[TBL] [Abstract][Full Text] [Related]
5. Elimination of a community-acquired methicillin-resistant Staphylococcus aureus infection in a nurse with atopic dermatitis.
Roesch A; Linde HJ; Landthaler M; Vogt T
Arch Dermatol; 2005 Dec; 141(12):1520-2. PubMed ID: 16365252
[No Abstract] [Full Text] [Related]
6. Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection.
Moellering RC
Clin Infect Dis; 2008 Apr; 46(7):1032-7. PubMed ID: 18444820
[TBL] [Abstract][Full Text] [Related]
7. Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureus skin infections.
Cohen PR; Grossman ME
J Am Acad Dermatol; 2004 Jul; 51(1):132-5. PubMed ID: 15243539
[No Abstract] [Full Text] [Related]
8. Community-acquired methicillin-resistant Staphylococcus aureus: not just a spider bite.
Vozdecky C
Fam Community Health; 2009; 32(1):76-84. PubMed ID: 19092436
[TBL] [Abstract][Full Text] [Related]
9. Methicillin-resistant Staphylococcus aureus and athletes.
Kirkland EB; Adams BB
J Am Acad Dermatol; 2008 Sep; 59(3):494-502. PubMed ID: 18550208
[TBL] [Abstract][Full Text] [Related]
10. The treatment of community-acquired methicillin-resistant Staphylococcus aureus infections.
Fergie J; Purcell K
Pediatr Infect Dis J; 2008 Jan; 27(1):67-8. PubMed ID: 18162942
[No Abstract] [Full Text] [Related]
11. Genital community-associated methicillin resistant Staphylococcus aureus infection can be a sexually transmitted disease.
Roberts JR; McCawley L; Laxton M; Trumbo H
Ann Emerg Med; 2007 Jul; 50(1):93-4. PubMed ID: 17572298
[No Abstract] [Full Text] [Related]
12. Therapy-resistant skin and soft tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus in a young immunocompetent adult.
Graue N; Korber A; Schmid EN; Rath PM; Dissemond J
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):766-7. PubMed ID: 18482040
[No Abstract] [Full Text] [Related]
13. Bullous erysipelas caused by community-acquired methicillin-resistant Staphylococcus aureus.
Del Giudice P; Blanc-Amrane V
Dermatology; 2007; 214(2):191-2; author reply 192-3. PubMed ID: 17341875
[No Abstract] [Full Text] [Related]
14. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.
Stryjewski ME; Chambers HF
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S368-77. PubMed ID: 18462092
[TBL] [Abstract][Full Text] [Related]
15. High recurrence rate of CA-MRSA skin and soft tissue infections.
Skiest DJ; Cooper TW
Arch Intern Med; 2007 Dec; 167(22):2527author reply 2527. PubMed ID: 18071179
[No Abstract] [Full Text] [Related]
16. Caution when reconsidering empiric antimicrobial therapy for methicillin-resistant Staphylococcus aureus skin and soft-tissue infections.
da Silva LV; Zavascki AP; de Souza MV; Marcadenti A
Am J Surg; 2008 Oct; 196(4):618-9. PubMed ID: 18809069
[No Abstract] [Full Text] [Related]
17. No decrease in clindamycin susceptibility despite increased use of clindamycin for pediatric community-associated methicillin-resistant Staphylococcus aureus skin infections.
Szczesiul JM; Shermock KM; Murtaza UI; Siberry GK
Pediatr Infect Dis J; 2007 Sep; 26(9):852-4. PubMed ID: 17721387
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic options for treating community-acquired MRSA.
Powell JP; Wenzel RP
Expert Rev Anti Infect Ther; 2008 Jun; 6(3):299-307. PubMed ID: 18588495
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
Laupland KB; Ross T; Gregson DB
J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
[TBL] [Abstract][Full Text] [Related]
20. [Community MRSA].
Witte W; Mielke M
Zentralbl Chir; 2007 Apr; 132(2):124-9. PubMed ID: 17516318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
